Tapdıgova, R. Et Al. 2022. Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects. Naunyn-Schmiedeberg's Archives of Pharmacology , vol.395, no.6 , 673-680.

Tapdıgova, R., Bayrak, G., Yılmaz, B. C., & Aytan, H., (2022). Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects. Naunyn-Schmiedeberg's Archives of Pharmacology , vol.395, no.6, 673-680.

Tapdıgova, Raziyya Et Al. "Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects," Naunyn-Schmiedeberg's Archives of Pharmacology , vol.395, no.6, 673-680, 2022

Tapdıgova, Raziyya Et Al. "Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects." Naunyn-Schmiedeberg's Archives of Pharmacology , vol.395, no.6, pp.673-680, 2022

Tapdıgova, R. Et Al. (2022) . "Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects." Naunyn-Schmiedeberg's Archives of Pharmacology , vol.395, no.6, pp.673-680.

@article{article, author={Raziyya Tapdıgova Et Al. }, title={Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects}, journal={Naunyn-Schmiedeberg's Archives of Pharmacology}, year=2022, pages={673-680} }